Valuation Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq 00:00:00 29/10/2026 +04			5-day change	1st Jan Change
529.69 ^USD	+1.66%		+0.99%	+16.84%

10-28	ConvaTec to Spend GBP500 Million on New Global R&D Hub in Manchester, England, Over Next Decade	MT
10-24	Vertex Pharmaceuticals Incorporated Presents at American Society of Nephrology Kidney Week 2026, Oct-23-2026 06:15 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	134,256	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	16.72%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	126,552	124,239	121,481
Change	-	31.13%	47.8%	4.23%	11.09%	16.73%	-1.83%	-2.22%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	31.4x	28.5x	23.4x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	7.74x	6.25x	5.1x
PEG	-	0.5x	3.51x	2x	-0x	3.1x	2.8x	1.1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	10.1x	9.2x	8.1x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	9.53x	8.51x	7.33x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	26.7x	19.5x	16.4x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	22.6x	20.3x	16.6x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	70.2x	26.2x	23.5x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	1.43%	3.82%	4.25%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	16.85	18.59	22.68
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,276	14,598	16,566
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	4,746	6,367	7,421
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,611	6,129	7,322
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,376	4,867	5,892
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-7,704	-10,017	-12,775
Reference price ²	219.60	288.78	406.89	402.70	453.36	529.69	529.69	529.69
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,461	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	31.43x	9.53x	26.66x	-.--%	134B
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.75x	7.35x	19.62x	1.9%	417.14B
Weighted average by Cap.	35.16x	8.43x	20.83x	1.73%